The incidence rate of ALS is growing, making the need for treatments increasingly urgent. In every ALS clinical trial, we apply the full breadth of our scientific expertise, operational insights, and the support of our partner, TRICALS, which has a strong European network of ALS-specific sites.
Our scientific leader in ALS is Prof. dr. Leonard van den Berg, professor of neurology at the University Medical Centre (UMC) Utrecht and director of ALS Centrum Nederland (the Dutch ALS Centre). He has vast experience in global ALS trials, established the prominent ALS site network TRICALS, and chairs the European Network to Cure ALS.
Brain Clinical is our proprietary network for CNS studies, providing highly experienced researchers for CNS clinical trials.
We are proud to partner with TRICALS, the largest European research initiative to find a cure and effective treatments for ALS. Our partnership with TRICALS provides innovative trial design and oversight capabilities combined with seasoned operational efficiency. With their help, we provide excellent patient recruitment and retention to support optimal execution for your ALS study.
Whether your project is a Phase I– III clinical trial, an investigator-initiated trial, an observational study or includes Real World Data; we have many years of experience in clinical trials in the field of ALS and provide you with a tailor-made solution that suits your needs.
On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trialsDuring this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:Cognitive domains – which ones sho...
Explore our ALS trial capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields
